| tüüp : |
ajaleht |
| interneti link : |
https://doi.org/10.1007/s40268-019-0264-1 |
|
| uurimisrühmad : |
Menges - Novartis, Menges, Slovenia |
| Autor : |
Vimpolsek M, Gottar-Guillier M, Rossy E. |
| pealkiri : |
Assessing the Extended In-Use Stability of the Infliximab Biosimilar PF-06438179/GP1111 Following Preparation for Intravenous Infusion. |
| publikatsioon : |
Drugs R D 19: 127–140. 2019 |
|
| Tõendite tase : |
|
| füüsikaline stabiilsus : |
|
| Keemiline püsivus : |
|
| Muud meetodid : |
|
| Kommentaarid : |
| Valgud: bioloogiline aktiivsus rakukultuuris |
|
ingredientide nimekiri
 Infliximab
|
 |
 |
 |
 |
10 mg/ml |
2-8°C |
 |
| 30 |
 |
|
 |
|
|
|
10 mg/ml |
23-27°C |
|
| 14 |
|
|
|
|
 |
 |
0,4 mg/ml |
2-8°C |
|
| 30 |
|
|
|
|
|
|
0,4 mg/ml |
23-27°C |
|
| 30 |
|
|
|
|
|
|
4 mg/ml |
2-8°C |
|
| 30 |
|
|
|
|
|
|
4 mg/ml |
23-27°C |
|
| 30 |
|
|
|
|
|
